Enterome
PrivateLast Round
VC Round
Jun 12, 2025
Total Funding Raised
$177.99M
Momentum Score
50 /100
Company Overview
Enterome is a biotechnology company specializing in the development of pharmaceuticals and diagnostic tests aimed at creating off-the-shelf, transformative cancer treatments that harness the patient's own immune response to target all tumor types.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enterome Comps
Public and private peers based on sector, stage, and business model.
Enterome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 12, 2025 | ||||
| Early Funding | Aug 25, 2023 | ||||
| Series E | Jun 25, 2020 | ||||
| Debt | Jan 4, 2018 | ||||
| Series D | Jan 4, 2018 | ||||
Series C | Apr 20, 2016 |
Key People
Founding team and executive leadership
Enterome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Series D, Series B, Series A, Series C |
| Natixis | VC Round, Series D, Series B, Series E, Series A |
| SymBiosis Capital Management | Series E |
| Lundbeckfonden BioCapital | VC Round |
| INRAE Transfert | Series C |
| European Investment Bank Group | Debt |
| Lundbeck | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Mehrdad Mobasher, M.D., M.P.H. joins the Board of Directors.
- May 30, 2025
Positive data from Phase 1/2 trial of EO4010 for metastatic colorectal cancer.
Enterome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enterome's valuation, stock price, and market status.
